Involvement of IFN-γ and perforin, but not Fas/FasL interactions in regulatory T cell-mediated suppression of experimental autoimmune encephalomyelitis

Journal of Neuroimmunology

Volumn 229, Issue 1-2, 2010, Pages 91-97

  Beeston, Tara ^a   Smith, Trevor R F ^a   Maricic, Igor ^a   Tang, Xiaolei ^a   Kumar, Vipin ^a  

^a TORREY PINES INSTITUTE FOR MOLECULAR STUDIES   (United States)

Author keywords

EAE; Fas FasL; Perforin; Regulatory T cells; TCR vaccination

Indexed keywords

CD8ALPHA ANTIGEN; FAS ANTIGEN; FAS LIGAND; GAMMA INTERFERON; PEPTIDE VACCINE; PERFORIN; T LYMPHOCYTE RECEPTOR ALPHA CHAIN; T LYMPHOCYTE RECEPTOR BETA CHAIN;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTECTION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REGULATORY T LYMPHOCYTE; VACCINATION;

ANIMALS; ANTIGENS, CD4; ANTIGENS, CD8; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; INTERFERON-GAMMA; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MYELIN BASIC PROTEINS; PERFORIN; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; STATISTICS, NONPARAMETRIC; T-LYMPHOCYTES, REGULATORY;

EID: 78650307650     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2010.07.007     Document Type: Article

References (55)

1. Acha-Orbea H., Mitchell D.J., Timmermann L., Wraith D.C., Tausch G.S., Waldor M.K., Zamvil S.S., McDevitt H.O., Steinman L. Limited heterogeneity of T cell receptors from lymphocytes mediating autoimmune encephalomyelitis allows specific immune intervention. Cell 1988, 54:263.
2. Badovinac V.P., Tvinnereim A.R., Harty J.T. Regulation of antigen-specific CD8+ T cell homeostasis by perforin and interferon-gamma. Science 2000, 290:1354.
3. Bevan M.J. Helping the CD8(+) T-cell response. Nat. Rev. Immunol. 2004, 4:595.
4. Boissonnas A., Scholar-Dahirel A., Simon-Biancal V., Pace L., Valet F., Kissenpfennig A., Sparwasser T., Malissen B., Fetler L., Amigorena S. Foxp3+ T cells induce perforin-dependent dendritic cell death in tumor-draining lymph nodes. Immunity 2010, 32:266.
5. Bouillet P., Metcalf D., Huang D.C., Tarlinton D.M., Kay T.W., Kontgen F., Adams J.M., Strasser A. Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity. Science 1999, 286:1735.
6. Braciak T.A., Pedersen B., Chin J., Hsiao C., Ward E.S., Maricic I., Jahng A., Graham F.L., Gauldie J., Sercarz E.E., Kumar V. Protection against experimental autoimmune encephalomyelitis generated by a recombinant adenovirus vector expressing the V beta 8.2 TCR is disrupted by coadministration with vectors expressing either IL-4 or -10. J. Immunol. 2003, 170:765.
7. Brunner T., Mogil R.J., LaFace D., Yoo N.J., Mahboubi A., Echeverri F., Martin S.J., Force W.R., Lynch D.H., Ware C.F. Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature 1995, 373:441.
8. Clark-Lewis I., Aebersold R., Ziltener H., Schrader J.W., Hood L.E., Kent S.B. Automated chemical synthesis of a protein growth factor for hemopoietic cells, interleukin-3. Science 1986, 231:134.
9. Correale J., Villa A. Isolation and characterization of CD8+ regulatory T cells in multiple sclerosis. J. Neuroimmunol. 2008.
10. Dowling P., Shang G., Raval S., Menonna J., Cook S., Husar W. Involvement of the CD95 (APO-1/Fas) receptor/ligand system in multiple sclerosis brain. J. Exp. Med. 1996, 184:1513.
11. D'Souza S.D., Bonetti B., Balasingam V., Cashman N.R., Barker P.A., Troutt A.B., Raine C.S., Antel J.P. Multiple sclerosis: Fas signaling in oligodendrocyte cell death. J. Exp. Med. 1996, 184:2361.
12. Griffith T.S., Kazama H., VanOosten R.L., Earle J.K., Herndon J.M., Green D.R., Ferguson T.A. Apoptotic cells induce tolerance by generating helpless CD8+ T cells that produce TRAIL. J. Immunol. 2007, 178:2679.
13. Grossman W.J., Verbsky J.W., Barchet W., Colonna M., Atkinson J.P., Ley T.J. Human T regulatory cells can use the perforin pathway to cause autologous target cell death. Immunity 2004, 21:589.
14. Hauser S.L., Bhan A.K., Gilles F., Kemp M., Kerr C., Weiner H.L. Immunohistochemical analysis of the cellular infiltrate in multiple sclerosis lesions. Ann. Neurol. 1986, 19:578.
15. Hilliard B., Wilmen A., Seidel C., Liu T.S., Goke R., Chen Y. Roles of TNF-related apoptosis-inducing ligand in experimental autoimmune encephalomyelitis. J. Immunol. 2001, 166:1314.
16. Hu D., Ikizawa K., Lu L., Sanchirico M.E., Shinohara M.L., Cantor H. Analysis of regulatory CD8 T cells in Qa-1-deficient mice. Nat. Immunol. 2004, 5:516.
17. Huseby E.S., Liggitt D., Brabb T., Schnabel B., Ohlen C., Goverman J. A pathogenic role for myelin-specific CD8(+) T cells in a model for multiple sclerosis. J. Exp. Med. 2001, 194:669.
18. Ichikawa H., Ota K., Iwata M. Increased Fas antigen on T cells in multiple sclerosis. J. Neuroimmunol. 1996, 71:125.
19. Janssens W., Carlier V., Wu B., VanderElst L., Jacquemin M.G., Saint-Remy J.M. CD4+CD25+ T cells lyse antigen-presenting B cells by Fas-Fas ligand interaction in an epitope-specific manner. J. Immunol. 2003, 171:4604.
20. Jiang H., Zhang S.I., Pernis B. Role of CD8+ T cells in murine experimental allergic encephalomyelitis. Science 1992, 256:1213.
21. Jiang H., Braunstein N.S., Yu B., Winchester R., Chess L. CD8+ T cells control the TH phenotype of MBP-reactive CD4+ T cells in EAE mice. Proc. Natl. Acad. Sci. USA 2001, 98:6301.
22. Ju S.T., Panka D.J., Cui H., Ettinger R., El-Khatib M., Sherr D.H., Stanger B.Z., Marshak-Rothstein A. Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature 1995, 373:444.
23. Kagi D., Vignaux F., Ledermann B., Burki K., Depraetere V., Nagata S., Hengartner H., Golstein P. Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity. Science 1994, 265:528.
24. Karandikar N.J., Crawford M.P., Yan X., Ratts R.B., Brenchley J.M., Ambrozak D.R., Lovett-Racke A.E., Frohman E.M., Stastny P., Douek D.C., Koup R.A., Racke M.K. Glatiramer acetate (Copaxone) therapy induces CD8(+) T cell responses in patients. J. Clin. Invest. 2002, 109:641.
25. Koh D.R., Fung-Leung W.P., Ho A., Gray D., cha-Orbea H., Mak T.W. Less mortality but more relapses in experimental allergic encephalomyelitis in CD8-/- mice. Science 1992, 256:1210.
26. Kumar V. Homeostatic control of immunity by TCR peptide-specific Tregs. J. Clin. Invest. 2004, 114:1222.
27. Kumar V., Sercarz E.E. The involvement of T cell receptor peptide-specific regulatory CD4+ T cells in recovery from antigen-induced autoimmune disease. J. Exp. Med. 1993, 178:909.
28. Kumar V., Sercarz E. Induction or protection from experimental autoimmune encephalomyelitis depends on the cytokine secretion profile of TCR peptide-specific regulatory CD4 T cells. J. Immunol. 1998, 161:6585.
29. Kumar V., Kono D.H., Urban J.L., Hood L. The T-cell receptor repertoire and autoimmune diseases. Annu. Rev. Immunol. 1989, 7:657.
30. Kumar V., Maglione J., Thatte J., Pederson B., Sercarz E., Ward E.S. Induction of a type 1 regulatory CD4 T cell response following V beta 8.2 DNA vaccination results in immune deviation and protection from experimental autoimmune encephalomyelitis. Int. Immunol. 2001, 13:835.
31. Lu L., Kim H.J., Werneck M.B., Cantor H. Regulation of CD8+ regulatory T cells: interruption of the NKG2A-Qa-1 interaction allows robust suppressive activity and resolution of autoimmune disease. Proc. Natl. Acad. Sci. USA 2008, 105:19420.
32. Madakamutil L.T., Maricic I., Sercarz E., Kumar V. Regulatory T cells control autoimmunity in vivo by inducing apoptotic depletion of activated pathogenic lymphocytes. J. Immunol. 2003, 170:2985.
33. Malipiero U., Frei K., Spanaus K.S., Agresti C., Lassmann H., Hahne M., Tschopp J., Eugster H.P., Fontana A. Myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis is chronic/relapsing in perforin knockout mice, but monophasic in Fas- and Fas ligand-deficient lpr and gld mice. Eur. J. Immunol. 1997, 27:3151.
34. Martin R. HLA class I: friend and foe of multiple sclerosis. Nat. Med. 2008, 14:1150.
35. Pelfrey C.M., Tranquill L.R., Boehme S.A., McFarland H.F., Lenardo M.J. Two mechanisms of antigen-specific apoptosis of myelin basic protein (MBP)-specific T lymphocytes derived from multiple sclerosis patients and normal individuals. J. Immunol. 1995, 154:6191.
36. Ponomarev E.D., Dittel B.N. Gamma delta T cells regulate the extent and duration of inflammation in the central nervous system by a Fas ligand-dependent mechanism. J. Immunol. 2005, 174:4678.
37. Reddy J., Waldner H., Zhang X., Illes Z., Wucherpfennig K.W., Sobel R.A., Kuchroo V.K. Cutting edge: CD4+CD25+ regulatory T cells contribute to gender differences in susceptibility to experimental autoimmune encephalomyelitis. J. Immunol. 2005, 175:5591.
38. Sabelko K.A., Kelly K.A., Nahm M.H., Cross A.H., Russell J.H. Fas and Fas ligand enhance the pathogenesis of experimental allergic encephalomyelitis, but are not essential for immune privilege in the central nervous system. J. Immunol. 1997, 159:3096.
39. Sabelko-Downes K.A., Cross A.H., Russell J.H. Dual role for Fas ligand in the initiation of and recovery from experimental allergic encephalomyelitis. J. Exp. Med. 1999, 189:1195.
40. Sabelko-Downes K.A., Gimenez M.T., Suvannavejh G.C., Miller S.D., Russell J.H. Genetic control of pathogenic mechanisms in autoimmune demyelinating disease. J. Neuroimmunol. 2000, 110:168.
41. Smith T.R., Kumar V. Revival of CD8(+) Treg-mediated suppression. Trends Immunol. 2008, 29:337.
42. Steinman L. Multiple sclerosis: a coordinated immunological attack against myelin in the central nervous system. Cell 1996, 85:299.
43. Stepp S.E., Dufourcq-Lagelouse R., Le D.F., Bhawan S., Certain S., Mathew P.A., Henter J.I., Bennett M., Fischer A., de Saint B.G., Kumar V. Perforin gene defects in familial hemophagocytic lymphohistiocytosis. Science 1999, 286:1957.
44. Sun D., Ben-Nun A., Wekerle H. Regulatory circuits in autoimmunity: recruitment of counter-regulatory CD8+ T cells by encephalitogenic CD4+ T cell lines. Eur. J. Immunol. 1988, 18:1993.
45. Tang X., Maricic I., Purohit N., Bakamjian B., Reed-Loisel L.M., Beeston T., Jensen P., Kumar V. Regulation of immunity by a novel population of Qa-1-restricted CD8alphaalpha+TCRalphabeta+ T cells. J. Immunol. 2006, 177:7645.
46. Tang X., Maricic I., Kumar V. Anti-TCR antibody treatment activates a novel population of nonintestinal CD8 alpha alpha+ TCR alpha beta+ regulatory T cells and prevents experimental autoimmune encephalomyelitis. J. Immunol. 2007, 178:6043.
47. Tennakoon D.K., Mehta R.S., Ortega S.B., Bhoj V., Racke M.K., Karandikar N.J. Therapeutic induction of regulatory, cytotoxic CD8+ T cells in multiple sclerosis. J. Immunol. 2006, 176:7119.
48. Traugott U., Reinherz E.L., Raine C.S. Multiple sclerosis: distribution of T cell subsets within active chronic lesions. Science 1983, 219:308.
49. Urban J.L., Kumar V., Kono D.H., Gomez C., Horvath S.J., Clayton J., Ando D.G., Sercarz E.E., Hood L. Restricted use of T cell receptor V genes in murine autoimmune encephalomyelitis raises possibilities for antibody therapy. Cell 1988, 54:577.
50. Viglietta V., Baecher-Allan C., Weiner H.L., Hafler D.A. Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis. J. Exp. Med. 2004, 199:971.
51. Waisman A., Ruiz P.J., Hirschberg D.L., Gelman A., Oksenberg J.R., Brocke S., Mor F., Cohen I.R., Steinman L. Suppressive vaccination with DNA encoding a variable region gene of the T-cell receptor prevents autoimmune encephalomyelitis and activates Th2 immunity. Nat. Med. 1996, 2:899.
52. Waldner H., Sobel R.A., Howard E., Kuchroo V.K. Fas- and FasL-deficient mice are resistant to induction of autoimmune encephalomyelitis. J. Immunol. 1997, 159:3100.
53. Yang Y., Ratts R.B., Hussain R.Z., Northrop S.C., Ben L.H., Lovett-Racke A., Racke M.K. CD28:B7 interaction is necessary for the protective effect of T cell vaccination in EAE. Eur. J. Immunol. 2007, 37:2032.
54. York N.R., Mendoza J.P., Ortega S.B., Benagh A., Tyler A.F., Firan M., Karandikar N.J. Immune regulatory CNS-reactive CD8+ T cells in experimental autoimmune encephalomyelitis. J. Autoimmun. 2010, 35:33.
55. Zhang J., Medaer R., Stinissen P., Hafler D., Raus J. MHC-restricted depletion of human myelin basic protein-reactive T cells by T cell vaccination. Science 1993, 261:1451.